Personal information

Countries

Japan

Activities

Collapse all

Employment (8)

National Cancer Center Japan: Kashiwa, Chiba, JP

2024-06-01 to present | Director (Exploratory Oncology Research and Clinical Trial Center)
Employment
Source: Self-asserted source
Katsuya Tsuchihara

The University of Tokyo: Kashiwa, Chiba, JP

2014-04-01 to present | Visiting Professor (Graduate School of Frontier Sciences)
Employment
Source: Self-asserted source
Katsuya Tsuchihara

National Cancer Center Japan: Kashiwa, Chiba, JP

2012-07-01 to present | Chief (Exploratory Oncology Research and Clinical Trial Center)
Employment
Source: Self-asserted source
Katsuya Tsuchihara

National Cancer Center Japan: Kashiwa, Chiba, JP

2022-04-01 to 2024-05-31 | Deputy Director (Exploratory Oncology Research and Clinical Trial Center)
Employment
Source: Self-asserted source
Katsuya Tsuchihara

The University of Tokyo: Kashiwa, Chiba, JP

2010-04-01 to 2014-03-31 | Visiting Associate Professor (Graduate School of Frontier Sciences)
Employment
Source: Self-asserted source
Katsuya Tsuchihara

National Cancer Center Japan: Kashiwa, Chiba, JP

2005-04-01 to 2012-06-30 | Head (Research Center for Innovative Oncology)
Employment
Source: Self-asserted source
Katsuya Tsuchihara

Ontario Cancer Institute: Toronto, Ontario, CA

2000-04-01 to 2005-03-31 | Research Fellow
Employment
Source: Self-asserted source
Katsuya Tsuchihara

Japan Society for the Promotion of Science: Chiyoda-ku, Tokyo, JP

1998-04-01 to 2000-03-31 | Research Fellow
Employment
Source: Self-asserted source
Katsuya Tsuchihara

Education and qualifications (2)

Tokyo Medical and Dental University: Bunkyo-ku, Tokyo, JP

1996-04-01 to 2000-03-31 | Ph.D. (Graduate School of Medicine)
Education
Source: Self-asserted source
Katsuya Tsuchihara

Kanazawa University: Kanazawa, Ishikawa, JP

1987-04-01 to 1993-03-31 | M.D. (Medical School)
Education
Source: Self-asserted source
Katsuya Tsuchihara

Peer review (1 review for 1 publication/grant)

Review activity for International journal of clinical oncology. (1)
How many people are using ORCID?